ArticleInternational journal of nanomedicine2016

In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer.

Shaomei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.